NCT07564102Not yet recruitingPhase 1/2
dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy
dMD-002 US Pilot Study A Single-center, Randomized, Double-blind, Pilot Study to Assess the Efficacy and Safety of dMD-002 in Patients After Radical Prostatectomy
Source: ClinicalTrials.gov · Last updated 15 May 2026
Brief summary (registry, in English)
The purpose of this study is to conduct a US Pilot study of dMD-002 as a peripheral nerve repair sheet in patients with cavernous nerve injury following radical prostatectomy. The study will determine which endpoints and timepoints will be used for the pivotal study.
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 26 Apr 2026
- Start date
- 1 Aug 2026
- Primary completion date
- 30 Sept 2027
- Lead sponsor
- Mochida Medical USA, Inc.
- Diseases
- Prostate cancer
- NCT number
- NCT07564102
What you commit to
- Study type: Interventional · Phase 1/2
- Planned participants: 30
- From 1 Aug 2026 to the primary completion date, 30 Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients undergoing pre-surgery or post-surgery radiation therapy, hormone therapy, or anti-cancer therapy.
- Patients with a history of transurethral resection, laser therapy, microwave therapy, radiofrequency ablation, cryoablation, or other prostate surgery.
- etc.
Other
- Patients who have used a penile prosthesis implantation.
Who the study is looking for
- Patients diagnosed with prostate cancer.
- Patients scheduled to undergo a robot-assisted radical prostatectomy (including either bilateral-nerve sparing or unilateral-nerve sparing) for treatment of prostate cancer.
- etc.
Age in the registry: 40 years to 74 years · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Icahn School of Medicine at Mount Sinai Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.